Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35a pseudogene 5 (RPL35AP5) is a processed pseudogene originating from the ribosomal protein L35a gene. Pseudogenes like RPL35AP5 are genetically similar to known protein-coding genes but lack the ability to produce functional protein products. While pseudogenes can sometimes regulate their parental genes post-transcriptionally by acting as RNA decoys or miRNA sponges, there is no specific evidence for RPL35AP5 having functional relevance or disease association in the biomedical literature. It is not considered a molecular drug target, nor does it encode a functional ribosomal subunit.
None documented; no drugs or therapies directly target RPL35AP5.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 5 (RPL35AP5).